Sunday, September 13, 2026

Aspen Group Stock Is 2.77% Down So Far On Friday

ViaNews Editorial Team

December 4, 2020

Aspen Group Stock Is 2.77% Down So Far On Friday
Shares of Aspen Group dropped 2.77% to $11.41 at 14:09 EST on Friday, following yesterday's upward trend. The Nasdaq Stock Market is jumping 0.56% to $12,446.80, following yesterday's upward trend, on what at the moment seems, a somewhat positive trend trading session today. Aspen Group's last close was $11.74, 15.34% under its 52-week high of $13.16.

Aspen Group's Sales

The company's growth estimates for the current quarter is a negative 33.3% and positive 75% for the next.

Aspen Group's Revenue

Year-on-year quarterly revenue growth grew by 46.4%, now sitting on 53.87M for the twelve trailing months.

Aspen Group's Stock Top and Bottom Yearly Value

Aspen Group's stock is valued at $11.41 at 14:09 EST, way under its 52-week high of $13.16 and way higher than its 52-week low of $4.65.

Aspen Group's Moving Average

Aspen Group's worth is above its 50-day moving average of $10.96 and above its 200-day moving average of $10.45.
ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Chip Boom Lifts Semiconductors as Export-Control Gaps Persist
AI infrastructure demand is fueling a broad semiconductor rally — Broadcom's AI chip revenue and Q4 guidance, Amazon's custom silicon crossing a $25B annual run rate, and bullish analyst calls on Micron and Sandisk tied to a memory chip boom underestimated even by bulls — with ASML rallying on sympathy. That momentum runs alongside unresolved US-China tech tensions: Belgium's arrest of a suspect for stealing chip technology for China and a blacklisted Chinese firm still acquiring Nvidia's top AI chips show export-control enforcement lagging the pace of AI chip demand.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,280 source documents archived
Query this data → isubstrate.com